Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 917-923

  Nie, Yongzhan ^a,b   Hammond, Graeme L ^a   Yang, Jing Hua ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DOUBLE STRANDED RNA; PROTEIN ADAR1; PROTEIN KINASE R; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEAMINATION; ENZYME ANALYSIS; ENZYME INHIBITION; ERYTHROPOIESIS; FIBROBLAST; HOST SUSCEPTIBILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; RNA EDITING; RNA INTERFERENCE; RNA SEQUENCE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ADENOSINE DEAMINASE; ANIMALS; CELL LINE; EIF-2 KINASE; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-2; HUMANS; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; RNA, DOUBLE-STRANDED; RNA, VIRAL; VESICULAR STOMATITIS-INDIANA VIRUS;

EUKARYOTA; VESICULAR STOMATITIS VIRUS;

EID: 33846073016     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01527-06     Document Type: Article

References (32)

1. Balachandran, S., and G. N. Barber. 2000. Vesicular stomatitis virus (VSV) therapy of tumors. IUBMB Life 50:135-138.
2. Balachandran, S., P. C. Roberts, L. E. Brown, H. Truong, A. K. Pattnaik, D. R. Archer, and G. N. Barber. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-141.
3. Cattaneo, R. 1994. Biased (A 3 I) hypermutation of animal RNA virus genomes. Curr. Opin. Genet. Dev. 4:895-900.
4. Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M. A. Billeter. 1988. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55:255-265.
5. Dalton, K. P., and J. K. Rose. 2001. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology 279:414-421.
6. de Haro, C., R. Mendez, and J. Santoyo. 1996. The eIF-2α kinases and the control of protein synthesis. FASEB J. 10:1378-1387.
7. Der, S. D., Y. L. Yang, C. Weissmann, and B. R. Williams. 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:3279-3283.
8. Durbin, R. K., S. E. Mertz, A. E. Koromilas, and J. E. Durbin. 2002. PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. Viral Immunol. 15:41-51.
9. Hartwig, D., C. Schutte, J. Warnecke, I. Dorn, H. Hennig, H. Kirchner, and P. Schlenke. 2006. The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells. J. Viral Hepat. 13:150-157.
10. Huang, Y., and Z. R. Liu. 2002. The ATPase, RNA unwinding, and RNA binding activities of recombinant p68 RNA helicase. J. Biol. Chem. 277: 12810-12815.
11. Jagus, R., and M. M. Gray. 1994. Proteins that interact with PKR. Biochimie 76:779-791.
12. Jayan, G. C., and J. L. Casey. 2002. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2. J. Virol. 76:3819-3827.
13. Kumar, M., and G. G. Carmichael. 1997. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl. Acad. Sci. USA 94:3542-3547.
14. Langland, J. O., J. M. Cameron, M. C. Heck, J. K. Jancovich, and B. L. Jacobs. 2006. Inhibition of PKR by RNA and DNA viruses. Virus Res. 119:100-110.
15. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
16. Nie, Y., L. Ding, P. N. Kao, R. Braun, and J. H. Yang. 2005. ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Mol. Cell. Biol. 25:6956-6963.
17. Nie, Y., Q. Zhao, Y. Su, and J. H. Yang. 2004. Subcellular distribution of ADAR1 isoforms is synergistically determined by three nuclear discrimination signals and a regulatory motif. J. Biol. Chem. 279:13249-13255.
18. Parker, L. M., I. Fierro-Monti, and M. B. Mathews. 2001. Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase. J. Biol. Chem. 276:32522-32530.
19. Patel, R. C., D. J. Vestal, Z. Xu, S. Bandyopadhyay, W. Guo, S. M. Erme, B. R. Williams, and G. C. Sen. 1999. DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR. J. Biol. Chem. 274:20432-20437.
20. Patterson, J. B., D. C. Thomis, S. L. Hans, and C. E. Samuel. 1995. Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. Virology 210:508-511.
21. Rabinovici, R., K. Kabir, M. Chen, Y. Su, D. Zhang, X. Luo, and J. H. Yang. 2001. ADAR1 is involved in the development of microvascular lung injury. Circ. Res. 88:1066-1071.
22. Ramsburg, E., J. Publicover, L. Buonocore, A. Poholek, M. Robek, A. Palin, and J. K. Rose. 2005. A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. J. Virol. 79: 15043-15053.
23. Roberts, A., E. Kretzschmar, A. S. Perkins, J. Forman, R. Price, L. Buonocore, Y. Kawaoka, and J. K. Rose. 1998. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72:4704-4711.
24. Schnell, M. J., L. Buonocore, E. Kretzschmar, E. Johnson, and J. K. Rose. 1996. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. USA 93:11359-11365.
25. Sharp, T. V., F. Moonan, A. Romashko, B. Joshi, G. N. Barber, and R. Jagus. 1998. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. Virology 250:302-315.
26. Sledz, C. A., M. Holko, M. J. de Veer, R. H. Silverman, and B. R. Williams. 2003. Activation of the Interferon system by short-interfering RNAs. Nat. Cell Biol. 5:834-839.
27. Stojdl, D. F., N. Abraham, S. Knowles, R. Marius, A. Brasey, B. D. Lichty, E. G. Brown, N. Sonenberg, and J. C. Bell. 2000. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol. 74:9580-9585.
28. Taylor, D. R., M. Puig, M. E. Darnell, K. Mihalik, and S. M. Feinstone. 2005. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 79:6291-6298.
29. Thomis, D. C., and C. E. Samuel. 1992. Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells. Proc. Natl. Acad. Sci. USA 89: 10837-10841.
30. Wang, Q., M. Miyakoda, W. Yang, J. Khillan, D. L. Stachura, M. J. Weiss, and K. Nishikura. 2004. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J. Biol. Chem. 279:4952-4961.
31. Williams, B. R. 2001. Signal integration via PKR. Sci. STKE 2001:RE2.
32. Zamanian-Daryoush, M., T. H. Mogensen, J. A. DiDonato, and B. R. Williams. 2000. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase. Mol. Cell. Biol. 20:1278-1290.